Davenport & Co’s Bausch Health BHC Stock Holding History

Davenport & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-12,550	Closed	-$200K	–	696
2018 Q1	$200K	Buy	+12,550	New	+$234K	﹤0.01%	646
2016 Q1	–	Sell	-4,395	Closed	-$447K	–	585
2015 Q4	$447K	Sell	4,395 -160,230	-97%	-$18M	0.01%	378
2015 Q3	$29.4M	Sell	164,625 -209	-0.1%	-$48.7K	0.49%	79
2015 Q2	$36.6M	Sell	164,834 -70	-0%	-$15.5K	0.57%	66
2015 Q1	$32.8M	Sell	164,904 -89,314	-35%	-$15.8M	0.5%	81
2014 Q4	$36.4M	Sell	254,218 -5,158	-2%	-$694K	0.59%	69
2014 Q3	$34M	Sell	259,376 -1,300	-0.5%	-$155K	0.59%	61
2014 Q2	$32.9M	Buy	260,676 +3,022	+1%	+$386K	0.56%	70
2014 Q1	$34M	Buy	257,654 +1,452	+0.6%	+$199K	0.62%	61
2013 Q4	$30.1M	Buy	+256,202	New	+$28.1M	0.56%	73

Other funds holding BHC

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Davenport & Co's BHC Position: Q2 2018 in Review

Davenport & Co sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 12,550 shares — an estimated $200K sold.

Davenport & Co first reported a position in BHC in Q4 2013 and held it in 10 quarters. The position peaked at $36.6M in Q2 2015. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

Davenport & Co reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
Davenport & Co sold 12,550 Bausch Health shares in Q2 2018, an estimated $200K.
Davenport & Co first reported a position in Bausch Health in Q4 2013 and held it in 10 quarters.
Davenport & Co's Bausch Health position peaked at $36.6M in Q2 2015.
311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Davenport & Co's 13F filing for Q2 2018, filed 9 Jul 2018.